Halabi, S., Roy, A., Guo, S. S., Rydzewska, L., Godolphin, P., Hussain, M. H. A., … Sweeney, C. (2023). Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Halabi, Susan, Akash Roy, Siyuan S. Guo, Larysa Rydzewska, Peter Godolphin, Maha H. A. Hussain, Catherine Tangen, et al. “Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Halabi S, Roy A, Guo SS, Rydzewska L, Godolphin P, Hussain MHA, et al. Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC). In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Halabi, Susan, et al. “Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Halabi S, Roy A, Guo SS, Rydzewska L, Godolphin P, Hussain MHA, Tangen C, Thompson I, Xie W, Carducci MA, Smith MR, Morris MJ, Gravis G, Dearnaley DP, Verhagen P, Goto T, Tierney JF, James ND, Buyse ME, Sweeney C. Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC). JOURNAL OF CLINICAL ONCOLOGY. 2023.